Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

V. A. Jennings, E. J. Ilett, K. J. Scott, E. J. West, R. Vile, H. Pandha, K. Harrington, A. Young, G. D. Hall, M. Coffey, P. Selby, F. Errington-Mais, A. A. Melcher

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites'. Together they form a unique fingerprint.

Medicine & Life Sciences